Factory Direct XCE Tirzepatide - High Potency Diabetes Research Compound in Powder Form

XCE tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for type 2 diabetes research. This synthetic peptide demonstrates superior efficacy in glucose control and weight management compared to selective GLP-1 receptor agonists.

The compound exhibits preferential binding to GIP receptors while maintaining significant activity at GLP-1 receptors. This unique pharmacological profile results in enhanced glycemic control through glucose-dependent stimulation of insulin secretion and suppression of glucagon release.

Research applications include:

• Diabetes mellitus type 2 studies
• Metabolic syndrome research
• Obesity and weight management investigations
• Comparative pharmacology with other incretin mimetics

Storage and handling recommendations:

• Maintain at -20°C for long-term storage
• Protect from light and moisture
• Avoid repeated freeze-thaw cycles
• Use proper laboratory safety equipment when handling

This product is supplied as a lyophilized white powder with comprehensive analytical documentation including HPLC purity certificates and mass spectrometry verification. The material is packaged in sterile vials under inert atmosphere to ensure stability.

For research use only. Not for human or veterinary use. This material is intended solely for laboratory research purposes by qualified professionals in controlled settings.